D
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G/A295.1 KBDicerna Pharmaceuticals IncFeb 14, 6:11 AM ET·0001193125-22-039084
- 8-K253.8 KBDicerna Pharmaceuticals IncDec 28, 9:28 AM ET·0001193125-21-367447
- SC 13G276.1 KBDicerna Pharmaceuticals IncDec 3, 6:09 AM ET·0001193125-21-347158
- 8-K718.8 KBDicerna Pharmaceuticals IncNov 18, 8:31 AM ET·0001193125-21-333251
- 10-Q9.2 MBDicerna Pharmaceuticals IncNov 9, 7:49 AM ET·0001399529-21-000158
- 8-K430.3 KBDicerna Pharmaceuticals IncNov 9, 7:47 AM ET·0001399529-21-000157
- 10-Q7.3 MBDicerna Pharmaceuticals IncAug 9, 7:05 AM ET·0001399529-21-000142
- 8-K439.7 KBDicerna Pharmaceuticals IncAug 9, 7:03 AM ET·0001399529-21-000141
- 8-K3.9 MBDicerna Pharmaceuticals IncAug 6, 9:01 AM ET·0001399529-21-000137
- 8-K325.5 KBDicerna Pharmaceuticals IncJun 4, 4:08 PM ET·0001399529-21-000095
Insiders
10- Aradhye ShreeramEVP & Chief Medical Officer
- Bain Capital Life Sciences Fund, L.P.10% Owner
- Bain Capital Life Sciences Investors, LLC10% Owner
- BCIP Life Sciences Associates, LP10% Owner
- BLAIR JAMES C10% Owner
- Brown Bob DChief Scientific Officer
- BUCHI J KEVINDirector
- Ciappenelli Robert D.Chief Commercial Officer
- Doberstein Stephen KDirector
- Domain Partners VIII, L.P.10% Owner
Tickers
No tickers on record
Addresses
business
75 HAYDEN AVENUE
LEXINGTON, MA, 02421
mailing
75 HAYDEN AVENUE
LEXINGTON, MA, 02421